Figure 5From: Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, UK Change in days taking painkillers pre- and post-BOTOX in chronic migraine sufferers + . Back to article page